Uses of Voltaren

Voltaren 50mg drug belongs to the group of non-steroidal anti-inflammatory drugs (NSAIDs), with the main ingredient being Diclofenac sodium. Voltaren 50mg is used in rheumatoid arthritis, gout, menstrual cramps and pain after surgery.

Voltaren 50 contains Diclofenac sodium as the main ingredient. This active ingredient has the effect of reducing joint pain at rest or movement, reducing morning stiffness, joint swelling, improving joint function, reducing spontaneous pain when moving, reducing swelling in the case of inflammation and postoperative wound edema. In addition, Diclofenac sodium is also effective in relieving moderate and severe pain of non-rheumatic origin.
Voltaren 50 is made in the form of round light brown, enteric-coated, film-coated tablets. Voltaren 50 is indicated in the following cases:
Rheumatoid arthritis (including rheumatoid arthritis in young people), non-articular rheumatism, osteoarthritis, ankylosing spondylitis, spondyloarthritis, spinal pain syndrome. Exacerbation of gout. Relieves postoperative pain, trauma, inflammation and swelling (toothache). Pain relief in gynecological pain, gynecological inflammation (dysmenorrhea, adnexitis).

Voltaren 50 is to be taken by swallowing the tablet whole with a sufficient amount of water, do not break or chew. Should be taken before eating.
Dosage of Voltaren 50mg is adjusted depending on the patient. To limit the side effects of the drug, it is possible to reduce the maximum dose to the lowest level in the shortest time but still ensure the effectiveness of the drug. The maximum dose is 150mg/day.
Dosage of Voltaren 50 depends on each patient as follows:
To relieve joint pain in adults: Initially 100-150mg/day, if long-term treatment and milder condition, 75-100mg/day Day, divided into 2-3 times to use during the day. Voltaren 50mg suppositories can be used at bedtime to prevent stiffness at night and in the morning, however, the maximum dose should be 150mg/day. Relief of primary dysmenorrhea in adults: Initially 50-150 mg/day and may increase to a maximum of 200 mg/day over the next few menstrual cycles. It is best to start treatment with Voltaren 50mg at the first appearance of symptoms and whether or not to continue treatment depends on symptoms present. Treatment of arthritis in children over 1 year old and adolescents under 14 years old: 0.5 - 2 mg/kg body weight/day, divided into 2-3 times to use depending on the severity of the disease. The maximum dose can be up to 3mg/kg body weight/day in the treatment of rheumatoid arthritis and divided into several times a day. However, Voltaren 50mg is so high in strength that it is not recommended for use in children and adolescents, and Voltaren 25mg should be used instead. Elderly patients (over 65 years): Use the lowest effective dose. In the process of taking the drug, it is necessary to pay attention to monitoring for gastrointestinal bleeding. Patients with congestive heart failure (grade I) or with significant cardiovascular risk factors: Less than 100 mg/day if treatment is longer than 4 weeks. Overdose of Voltaren 50 can cause tinnitus, dizziness, vomiting, diarrhea, gastrointestinal bleeding, convulsions. If the poisoning is severe, the patient may experience acute kidney failure and liver damage. At that time, to manage acute poisoning, it is necessary to apply supportive measures and depending on complications such as stomach disorders, respiratory failure, kidney failure, hypotension, convulsions, there will be symptomatic treatment of edema. fit.

Voltaren 50 may cause some unwanted side effects with the following frequency:
Common: Dizziness, headache; abdominal pain, nausea, vomiting, loss of appetite, flatulence, indigestion, diarrhea; increased transaminases; rash on the skin. Uncommon: Chest pain, palpitations, heart failure, myocardial infarction. Rare: Anemia, thrombocytopenia, leukopenia, agranulocytosis; hypersensitivity, anaphylaxis, hypotension, shock, angioedema, neurogenic edema; insomnia, psychosis, irritability, disorientation, nightmares, depression; tremor, taste disturbance, convulsions, paresthesia, somnolence, memory loss, cerebrovascular accident, aseptic meningitis; Voltaren 50mg also rarely causes blurred vision, visual disturbances, double vision; hearing loss, tinnitus; vasculitis, hypertension; pneumonia; esophageal disorders, glossitis, constipation, intestinal stenosis, peptic ulcer disease, colitis, pancreatitis, hematemesis, gastrointestinal bleeding, melena; liver disorders, liver failure, jaundice, hepatitis, liver necrosis; urticaria, erythema, eczema, bullous dermatitis, exfoliative dermatitis, Stevens-Johnson syndrome, Lyell syndrome, photosensitive reaction, alopecia areata, pruritus, purpura; Tubulointerstitial nephritis, acute renal failure, nephrotic syndrome, hematuria, proteinuria, renal papillary necrosis; edema. If you see any unusual symptoms while taking Voltaren 50mg, you should stop taking it and contact your doctor, pharmacist or medical facility for safe and appropriate treatment, to limit the effects of the drug on your health. health and life.

Do not use Voltaren 50mg drug in people with hypersensitivity to the ingredients of the drug, people with peptic ulcer perforation, gastrointestinal bleeding or people with a history of gastric perforation, gastrointestinal bleeding due to NSAIDs, pregnant women In the last 3 months of pregnancy, people with severe liver and kidney failure, people with acute rhinitis, urticaria, asthma, people with congestive heart failure (grades II - IV), people with ischemic heart disease, pathology cerebrovascular disease, peripheral artery disease, children under 35 kg body weight. Caution should be exercised when using Voltaren 50 in the elderly (over 65 years old) because this is a group of subjects at high risk of complications, especially peptic ulcer, perforated ulcer, gastrointestinal bleeding. In patients with ulcerative colitis or Crohn's disease, the use of Voltaren 50 should be under close medical supervision. Periodically re-evaluate the patient's ability to respond to medication and the need for treatment in at-risk cardiovascular patients if treatment is to be continued for a long time (more than 4 weeks). If there are signs of arterial thrombosis such as shortness of breath, shortness of breath, chest pain, weakness, difficulty speaking, the patient should contact a doctor immediately. If treatment with Voltaren 50 for a long time, it is necessary to pay attention to monitor blood counts, especially patients with hemostasis disorders. Voltaren 50mg should be used with caution in people with asthma, seasonal allergic rhinitis, nasal polyps, chronic obstructive pulmonary disease, chronic respiratory infections, and other allergies. Regularly monitor and check liver function during treatment with Voltaren, especially long-term treatment. If there is abnormality in liver function indicators, stop taking the drug and contact a doctor. People with hepatic porphyria should be cautious when taking Voltaren because it can cause acute porphyria. Voltaren 50 should be discontinued at the first appearance of skin and mucosal symptoms such as rash or any other hypersensitivity reaction. Renal function should be monitored during treatment with Voltaren 50 to prevent early cardiac and renal damage. Voltaren 50mg can reduce fertility in women, so women who are trying, planning to become pregnant or having difficulty becoming pregnant should not take Voltaren. Women who are trying to conceive or are pregnant in the first trimester of pregnancy should be prescribed the lowest possible dose of Voltaren 50 and the shortest duration of treatment. Women who are breastfeeding should not take Voltaren because it is excreted in breast milk and affects the baby. Limit activities that require high concentration such as driving, operating machinery because Voltaren 50 can cause drowsiness, dizziness, dizziness, visual disturbances, central nervous system disorders. Voltaren 50 may interact with drugs: significantly increased peak plasma concentrations and diclofenac exposure when co-administered with CYP2C9 inhibitors; increased plasma concentrations of lithium and digoxin when administered concomitantly with lithium and digoxin; reduced antihypertensive effect when taken with diuretics or antihypertensives; increased nephrotoxicity when co-administered with ciclosporin and tacrolimus; increased serum potassium concentration when used concomitantly with potassium-sparing diuretics; cause convulsions when used concurrently with quinolones. In addition, several drug interactions are under review with Voltaren 50mg, including: increased frequency of gastrointestinal adverse events when used with corticosteroids or other nonsteroidal systemic anti-inflammatory drugs; increased risk of bleeding when used concomitantly with anticoagulants and antiplatelet agents; increased risk of gastrointestinal bleeding when used concurrently with selective serotonin reuptake inhibitors (SSRIs); increased concentrations and toxicity of methotrexate when used concomitantly with methotrexate; increased plasma phenytoin concentration when administered at the same time as Phenytoin; Hyperglycemia and hypoglycemia when used concurrently with antidiabetic drugs. To limit and avoid the effects of drug interactions, before taking Voltaren 50, patients need to tell their doctor/pharmacist about their medical history and any drugs they have been using, including: prescription and non-prescription drugs, dietary supplements, herbs. The use of Voltaren 50 is to reduce swelling and pain in joints in rheumatic or non-rheumatic diseases, relieve pain in gout, relieve pain after trauma or surgery and relieve pain in menstrual pain or gynecological inflammation.